ALEXANDRIA, Va. - The American Society of Clinical Oncology (ASCO) today issued a clinical practice guideline on human papillomavirus (HPV) vaccination for the prevention of cervical cancer. This is the first guideline on primary prevention of cervical cancer that is tailored to multiple regions of the world with different levels of socio-economic and structural resource settings, offering evidence-based guidance to health care providers worldwide.
We soundly oppose President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health (NIH). Reducing NIH’s funding by nearly 20 percent will devastate our nation’s already fragile federal research infrastructure and undercut a longstanding commitment to biomedical science that has fueled advances in cancer prevention, diagnosis, and treatment.
A new study demonstrates that the use of less radiation therapy (RT) for breast cancer patients who have undergone lumpectomy does not negatively impact patient outcomes, and could result in significant reductions in health care costs. These findings, which examine patient eligibility for evidence-based radiation therapies or no RT in the National Cancer Database (NCDB), were published online today in the Journal of Oncology Practice. People living with breast cancer often receive lumpectomy followed by RT instead of a full mastectomy because research has demonstrated that there is no difference in disease-specific or overall survival.
ALEXANDRIA, Va. -- On March 22, 2017, the American Society of Clinical Oncology (ASCO) will release The State of Cancer Care in America: 2017 report, which examines the current landscape of the cancer care delivery system in the United States, and outlines key opportunities and challenges facing cancer care providers and patients today.
“The American Society of Clinical Oncology (ASCO) congratulates Seema Verma for her confirmation as Administrator of the Centers for Medicare & Medicaid Services (CMS). Administrator Verma is now in a key position to lead the agency during the next phase of healthcare reform in the United States, and to help ensure that millions of Medicare and Medicaid beneficiaries with cancer have access to high-quality oncology care."
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO), and the Oncology Nursing Society (ONS) announced today the formation of the CancerLinQ® Ambassadors Program. This new collaboration is a national practice engagement initiative that will provide on-the-ground support and guidance to CancerLinQ® participating practices on a regional basis.
Alexandria, VA. – The Journal of Oncology Practice (JOP) today will publish three articles being presented in oral sessions at ASCO’s 2017 Quality Care Symposium (QCS) in Orlando, FL. In its aim to provide top resources on clinical and administrative management for the oncology field, JOP is extending its publishing territory to work with researchers and publish the latest findings in conjunction with meeting presentations.
ALEXANDRIA, Va. – Four studies exploring key issues in providing high-quality patient care will be presented at the 2017 Quality Care Symposium, taking place March 3–4, at Rosen Shingle Creek in Orlando, FL. These notable abstracts examine and implement various approaches to improving the quality of treatment and care for patients with cancer.
ALEXANDRIA, Va. – An influx of new oral cancer drugs provides patients with a more convenient and less invasive way to take medication, but such treatments are often associated with adherence challenges and medical errors. New research shows that the addition of an in-house specialty pharmacy at a cancer center in New Haven, Connecticut, improved overall quality of care for patients, reduced the amount of time it took patients to receive their medication, and prevented errors associated with filling, dispensing, and taking oral chemotherapy. Authors will present their findings at the American Society of Clinical Oncology’s (ASCO) upcoming Quality Care Symposium, taking place March 3-4, in Orlando, Florida.
ALEXANDRIA, Va. – As an increasing number of patients look to the internet for cancer information, researchers from the University of Alabama found that the websites of many National Cancer Institute (NCI)-designated cancer centers lack sufficient information to help patients with breast cancer understand all their treatment options and make well-informed decisions. It also found they are not fully accessible to Spanish-speaking patients and those using mobile devices. In contrast, websites of the NCI and the Susan G. Komen® had high-quality patient information. Researchers will present their findings at the American Society of Clinical Oncology’s (ASCO) upcoming Quality Care Symposium, taking place March 3-4, in Orlando, Florida.
ALEXANDRIA, Va. – A new analysis of data from the U.S. Military Health System finds that mood and adjustment disorders such as anxiety and depression were strong predictors of the annual number of outpatient visits, hospital admissions, and number of days in the hospital for patients with breast and prostate cancer. The study also found that between 2007 and 2014, mood and adjustment disorders increased 7% (21% to 28%) among breast cancer patients and 4% (9% to 13%) among prostate cancer patients. However, during this period the rate at which depression increased was identical for both groups. Authors will present their findings at the American Society of Clinical Oncology’s (ASCO) upcoming Quality Care Symposium, taking place March 3-4, in Orlando, Florida.
ALEXANDRIA, Va. –– The embargo has lifted on all abstracts from the 2017 Quality Care Symposium. Journalists may now report on these abstracts, which are publicly available at abstracts.asco.org.
ALEXANDRIA, Va. – CancerLinQ LLC and the American Society for Radiation Oncology (ASTRO) are partnering to bring radiation oncology expertise to CancerLinQ® and improve the care of cancer patients nationwide. ASTRO will provide guidance for the development of the CancerLinQ® platform to ensure that the system captures more relevant patient data to drive actionable decision-making in cancer care, as well as to advance public policy and population health issues. ASTRO also will use insights from CancerLinQ Discovery™ to improve the care of patients receiving radiation therapy.
ALEXANDRIA, Va. – A large population-based study suggests that the utility of certain types of biomarkers, known as tumor-infiltrating lymphocytes (TILs), to predict colorectal cancer survival depends on where the tumor originates in the body. Although prior research has shown an association between high TIL density and longer survival for patients with colorectal cancers, according to the authors this study is the first to examine the prognostic impact of TILs in regards to tumor location. The study will be presented at the upcoming 2017 ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando.
ALEXANDRIA, Va. – Researchers have found a link between microbes in the gut (the microbiome) and response to immunotherapy. In the study, the ability of patients with advanced melanoma to respond to PD-1 immune checkpoint inhibitors depended on the presence of a diverse microbiome as well as specific bacterial species. The study will be presented at the upcoming 2017 ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando.